“We cannot arrest our way out of the problem,” some advocates say.
Today an FDA advisory panel meets with lawmakers to hammer out voluntary best practices for doctors who prescribe opiates. But in loosening restrictions for such cases, the FDA opened a window for wider prescriptions — and for abuse.